Airship AI Reports First Quarter 2024 Financial Results
May 15, 2024 08:31 ET
|
Airship AI
Airship AI Reports First Quarter 2024 Financial Results
The Real Good Food Company to Participate in the 24th Annual B. Riley Institutional Investor Conference
May 15, 2024 08:31 ET
|
The Real Good Food Company, Inc.
CHERRY HILL, N.J., May 15, 2024 (GLOBE NEWSWIRE) -- The Real Good Food Company, Inc. (NASDAQ: RGF) (“Real Good Foods” or the “Company”), a leading health and wellness frozen and refrigerated foods...
Yield10 Bioscience Announces Delisting from Nasdaq
May 15, 2024 08:30 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., May 15, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) ("Yield10" or the "Company"), an agricultural bioscience company, today announced that Company has received a...
Safety Shot, Inc. (Nasdaq: SHOT) Announces Strategic C-Store Plans in Los Angeles with 7-Eleven
May 15, 2024 08:30 ET
|
Safety Shot, Inc.
JUPITER, FL, May 15, 2024 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT) is thrilled to announce it will be introducing Safety Shot into 50 targeted 7-Elevens in Los Angeles in June. Safety...
Hudson Technologies to Attend 24th Annual B. Riley Securities Institutional Investor Conference
May 15, 2024 08:30 ET
|
Hudson Technologies
Conference announcement
Sow Good Reports Strong First Quarter 2024 Results
May 15, 2024 08:30 ET
|
Sow Good Inc.
- Q1 Revenue Increased 20% Sequentially to $11.4 Million - - Commenced Trading on Nasdaq on May 2, 2024, Marking Key Corporate Milestone - IRVING, Texas, May 15, 2024 (GLOBE NEWSWIRE) --...
Adial Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
May 15, 2024 08:30 ET
|
Adial Pharmaceuticals, Inc
GLEN ALLEN, Va., May 15, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies...
Genasys Receives $2.7 Million U.S. Navy Order for LRAD Maritime Systems
May 15, 2024 08:30 ET
|
Genasys Inc.
SAN DIEGO, May 15, 2024 (GLOBE NEWSWIRE) -- Genasys Inc. (NASDAQ: GNSS), the global leader in Protective Communications, today announced a $2.7 million LRAD systems order from the U.S. Navy (Navy)....
Atossa Therapeutics Announces Last Patient, Last Dose in its Phase 2 Karisma-Endoxifen Clinical Trial
May 15, 2024 08:30 ET
|
Atossa Therapeutics, Inc.
SEATTLE, May 15, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”) today announced that the last patient in the Company’s Karisma-Endoxifen clinical trial...
Veru Announces Steven B. Heymsfield M.D. as the Principal Investigator for its Enobosarm Phase 2b Clinical Trial for High Quality Weight Loss
May 15, 2024 08:30 ET
|
Veru Inc.
MIAMI, FL, May 15, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high...